+ Click for EPISODE TRANSCRIPT

---

DISCLAIMER: This text is the output of AI based transcribing from an audio recording. Although the transcription is largely accurate, in some cases it is incomplete or inaccurate due to inaudible passages or transcription errors and should not be treated as an authoritative record. Nothing that you read here constitutes advice medical or otherwise. Always consult with a healthcare professional before making changes to a healthcare plan.

Scott Benner 0:00
Hello friends, and welcome to Episode 510 of the Juicebox Podcast.

On today's episode, Jake Leach returns, Jake is the Executive Vice President and Chief Technology Officer at Dexcom. Jake is responsible for the leadership of scientific research, engineering, product development and product management. He oversees the development of next generation products and leads a large organization of amazing people. I've actually lost track of the amount of times Jake has been on the show, but my best research tells me that the first time he was here was in 2016. Is it 2021 now? Wow. Okay. Jake is gonna answer some of your questions that you sent to me through the private Facebook group for the podcast. He's going to answer a couple of my questions. He's going to talk a little bit about what's going on. If you like Dexcom you're gonna love this episode. While you're listening? Do me a favor and remember that nothing you hear on the Juicebox Podcast should be considered advice, medical or otherwise, always consult a physician before making any changes to your health care plan. were becoming bold with insulin. Less than a month ago I interviewed Dexcom CEO Kevin Sayer and that's available at Episode 498, where we talk more nuts and bolts about Dexcom g seven. Are you all excited for Dexcom g7 to come out? I am. Just so you know, I'm geeking out over here. This show is sponsored today by the glucagon that my daughter carries g vo cuyp open. Find out more at G Vogue glucagon.com forward slash juice box. This episode is also sponsored by Omni pod. Now if you're listening to the show, you know that you may be eligible for a free 30 day trial of the Omni pod dash tubeless insulin pump. All you have to do is go to Omni pod comm Ford slash juice box to find out. But there's some new exciting news from Omni pod. And I'd like to share it with you right now. There is no need to wait for the next big thing. With the Omni pod promise, you can upgrade to Omni pods latest technologies for no additional costs as soon as they are available to you and covered by insurance terms and conditions apply. But you can find out everything you need to know all the details at Omni pod comm forward slash juice box. I don't want to waste any time because I'm looking. I'm looking at a pile of an absolute pile of questions here. From listeners for the first thing. And I guess Also, I'm excited because whenever I get you after I get Kevin, it means something's about to happen. So. So take a second just so I have it for posterity Introduce yourself, please.

Jake Leach 2:58
Hi, Scott. I'm Jake Leach. I'm the Chief Technology Officer at Dexcom. thrilled to be here. Thanks for the opportunity.

Scott Benner 3:05
I'm really excited to have you back. I appreciate you doing it. Thank you very much. So like I said, I I interviewed Kevin a little while ago, and he kind of went over some high level stuff that was happening. And I recognized from the cycle over and over again that it might mean we're getting close to the Dexcom g7. So I asked if I could get you back on the show. It's been a little bit since you've been here. And I'm excited to do this again. I don't know where to start, other than I should probably let you start I think where do you feel like things are at?

Jake Leach 3:38
There's so much happening. We just got some really exciting news last week with our API being approved real time API. So that was exciting in a lot of different ways. One because it expands our ecosystem for G six, and ultimately g seven as well. So this is a web API that allows third party developers of applications, mobile apps to connect directly to the Dexcom Cloud cloud and receive glucose readings directly in real time. So that's a big step. Our previous Web API was a retrospective. So the data was a bit delayed. Now this opens it up to real time, data. So it's exciting in that way. It's also exciting seeing that the FDA is getting back to device, you know, reviews, there's a lot of pandemic COVID related emergency authorizations that they're working on. And so it's really great to see them getting back to, to the diabetes devices, and we're excited to get that approval.

Scott Benner 4:32
Yeah, me too. Give me an example of where this API might work. I own I don't know, a smartwatch manufacturer. Like is that the idea?

Jake Leach 4:42
Sure. Yeah. So it's exactly right. It's got the Garmin one of the folks that we was quoted in our press release about this. They're looking at some really exciting, smartwatch connectivity. So they're, they're connected watches can display glucose. That's what they've got a bunch of different options that they're working on. But that's the idea. It allows for real time data display, and a multitude of different experiences whether it could be a smartwatch, it could be in a mobile app, like another example is livongo and teladoc. Right. teladoc is about remote care accessing physicians remotely. And the livongo platform is about Diab treating diabetes with the right level of support needed for the individual. Putting real time glucose data into that system basically takes the power of Dexcom CGM, the accuracy, the reliability of performance, and puts it right into their user experience within their mobile application. So it's a really exciting way to create different experiences for users around the reliability of Dexcom.

Scott Benner 5:44
How far does this travel? Like? I'm making this up right now. But could I hire an app developer and make a Juicebox Podcast app that also you could connect to your Dexcom?

Jake Leach 5:53
You could, as long as you follow, it is still considered a regulated medical device. So you have to have those types of classifications in controls, but it's not. You know, you could Scott, you absolutely could if you wanted to.

Scott Benner 6:08
She's gonna happen. You're imagining me as like a bathtub pharmacist right now I would actually like, like a person who understood what they were doing. So what I'm saying is, it's not limited to people you have agreements with right now, or you do business with already.

Jake Leach 6:21
Yeah, that's right. Any anybody? We have a website Dexcom, developer calm. And you can go there and basically access all of the information, how to get started with our API's? How to download the tool set. And then yeah, basically how to work with us. It's all there. And so we welcome folks to check it out.

Scott Benner 6:40
What's the reasoning like, from your perspective, from a business perspective to make this available? It's, you know,

Jake Leach 6:46
we can't solve, there's a, there's a lot of different experiences that people want or need around CGM within diabetes. And it's, it's basically we acknowledge that we can't do everything, we're not going to solve every problem, or provide every experience that's wanted. So we want to basically build an ecosystem around Dexcom, where we have Dexcom at the heart, but we allow others to create really exciting products around our CGM. And it just makes the user experience for our customers that much better. Yeah,

Scott Benner 7:21
I think it also ends up supporting the company backwards to it, right. Like the more things that are out there that people can use, it's, it's better for you guys and better for us. By by extension, I believe. Okay. So that's pretty exciting is that that's launched now that's good to go.

Jake Leach 7:38
Yeah, it's it's, it's, it's approved. And we've got partners that have been working with it actually already in a development format. And now that it's approved, as soon as they get their solutions ready, they can launch them.

Scott Benner 7:49
So talk about for a second because your app, I'm, I'm, I'm hoping I guess that you're gonna tell me that the the apps have been updated, and we're gonna see them when g seven comes out, right. So when people want things that are people want things updated all the time? Can you explain why that's not feasible? Because I'm assuming you've made things that you know, people want that you wish were in the original apps that you probably could slide in. But why doesn't it happen like that? Why does it happen in a big release? I guess?

Jake Leach 8:22
It's a you know, Scott, it's a great question that I'll answer the first one, around g seven. Yes, the G seven app is a completely new experience, it has a lot of similarities to G six. So it'll be familiar for people. But it is a much updated user experience, the startup wizard to get going and how to use the product is significantly enhanced. As well as the data display, we've got some of the clarity features built right into the g7 app. And there's a lot of other exciting things that we're actually holding some of them back, we're really excited to launch g7, we want we have some surprises. And there's some really exciting new stuff. So I can't talk about all of it. But what I can say is, we're really excited about it. And we think users are going to be going to be thrilled. to the to the second part about releases. It is true that often, the releases come in, in larger waves. And a lot of it has to do it with history. Historically, the FDA would review our products. You know, we had to show the FDA, the product, the validation and how it works before we could provide the customers with the new classification that we got with G six a class two designation, it does allow us to bring updates to the apps more frequently. And so what we've done is we've invested pretty significantly in building our software team up to be able to put out more releases per year than what we've been historically doing. We're really excited about it so users haven't quite seen the frequency yet come out but we are have a whole roadmap plan for g7 that once we launch it, we plan to update it quite frequently, with new functionality, new feature requests, there's a lot in the backlog of stuff that we want to do. And so the first step was getting that lower designation by the FDA so that we can get things out faster. And one point about that designation, the reason we got there was because with G six, the level performance and reliability the CGM got to a point where the FDA was comfortable. If you met those standards, the ice CGM standards that they set forth. If you meet those from a performance and reliability perspective, then they're comfortable with that being in class to product, which means we can bring a lot of things to users much more, much quicker than we used to in the past. So lots to come with with the app portfolio.

Scott Benner 10:51
Okay. Is there a conscious decision to build slowly when you're making a company? Like, I mean, I don't think I don't know how people think of it. But you know, when I think of you, I think of Omni pod, I think of stuff that I use every day in my mind, right? There must be this amazing place. It's huge. There's 1000s upon 1000s of people working there, and it's running around, but you start as a small company, you gain some success. But if you start just throwing people in, I imagine it could get overwhelming and things start heading off in the wrong direction is like is that like bringing an app developers as an example? Like, more slowly? Is that on purpose? You know,

Jake Leach 11:28
it is I think there's two ways I look at it, one way I look at it is it's always important to look at what's the number one priority for the team. And so for, as we look at our apps and our features, we're always working very hard to prioritize which one comes next. And it's all based on customer feedback, we listened to our customers, and there's plenty of requests. And so what we do is we look for the ones that based on their feedback are the most important, the most needed. The other thing that we always prioritize is anything for that the FDA wants to see, you know, they will continue to evolve to. And so priorities are important. And then the other thing is, as you mentioned, it, you know, the product of development team is the app that the users use the customers use. And it's so important to have a consistent experience and quality. Quality is also so important with software. And so it is important as you onboard team members that they understand the culture, they understand why we do it, they understand that we always put the customers first patient first. It's a it's a whole mindset. So we do have an onboarding program as we bring developers on. And it's both development and test. The testers that test our apps are just as important as the people who write them, because they're the ones who are guaranteeing that the users get the experience they deserve.

Scott Benner 12:46
Yeah, I wonder how much like I just got a picture sent to me the other day from a listener who's wearing four different g sevens. She's testing adhesives. And yeah, she's got them all over her. And I know that that. I mean, that's assumed, right that that stuff happens. But it takes time. And it's hard to find people to do stuff like that. Going back to the app for a second, how much does visual simplicity come into your thinking, like, so you're not overwhelmed, because I don't know how frequently I look at Arden's app to be perfectly honest with you, or how frequently she looks at it. But you don't want it to be like this. Information overload every time you sit, you want what you need. But you don't want more than that. I was wondering if that's a consideration.

Jake Leach 13:27
It's It's It's at the top of the list. Our user design group is very thoughtful in the way that we communicate information. And one of the things which IE seven was, we knew that we wanted to expand the capabilities of the app without making it overwhelming. So the way that the app is architected you, there's lots of new information you can access. But it's not. It's there with a quick at your fingertips, but it's not in your face. And so what it allows you to do is you can choose the experience you want. If you want to jump right to your clarity report, it's right there, you can go see time and range. And you can see daily stats, if you want, or you can just you don't even have to scroll down to that you can just stay on the the normal real time display page, which will be familiar for users. It's a lot like JSX. But the way that the information is organized, we purposefully designed it so that we could put more functionality into it without it being overwhelming, particularly for new users who are just, you know, you know, potentially newly diagnosed diabetes still learning about, you know, how different things affect their blood sugar. And so you want it to be as simple as possible. You want the alerts and the alarms to be accessible and easy to use.

Scott Benner 14:41
So I if I'm wrong about this, please stop me but I feel like perhaps as long as three years ago, I spent a number of hours over a number of different days giving my feedback about what I would want to see in a Dexcom app was that the start of this process that we're gonna see this year. It was Yeah, it was telling you Was this year? I didn't mean to. Yeah, that's what I did. No, no, no, it's

Jake Leach 15:03
definitely you're, you're gonna see. So those are the exact types of sessions that we do with with our users. And that's the idea we want to hear. Because, you know, we we've got a lot of folks at the company who use the product as well, yeah, and live with diabetes in or, you know, using the CGM to help manage. But isn't that nothing's better than customer feedback? So that's, that's exactly what it was those sessions were all about, what do we put into this app? What functionality? What experience do people want?

Scott Benner 15:32
Yeah, so I'm going to take a second to say something that I think is important for long term for people with type one, I think, whether it's going to be an algorithm on a pump, or your product or anything like it, at some point, there should be levels, expert levels of the app that you can unlock, maybe your doctor has to say okay to it, or something like that. But I'll use this example any of these algorithms that are coming out right now for pumps, right? control IQ on the pod five, they're not going to be as customizable as the Do It Yourself loop that exists in the world. Right? And so for the people who know that they can keep their blood sugar at 85, overnight, super steady, when the algorithms more customizable. And giving over to the idea that there are far more people who are probably walking around with a onesies that are eight 910 1112, and would just be thrilled to wear one of those algorithms and have a six and a half a one c that's super stable, right? Like that would be life changing for them. But how do you make it so that it helps everybody who's in every situation, and in my mind, it's like, it's like the way Photoshop does it you can click on the beginner the intermediate, or the Advanced tab and when you move up, you get more features is that anything that's ever talked about?

You heard me talk about it at the beginning of the show. Omni pod has a promise for you. The Omni pod promise says this. You can upgrade on the pods latest technologies for no additional cost as soon as they're available to you and covered by insurance. Think about that. Okay, now listen to this. You can get a free no obligation trial of the Omni pod dash right now by going to Omni pod comm Ford slash juicebox. Okay, so you may be eligible for a free 30 day trial right now you go to the link, you get started. Even you know if you love it, it's great. The first 30 days are still free, so you get a free 30 days. And then if on the pod should ever come out with a new product, the Omni pod promise covers you. You can upgrade Omni pods latest technologies for no additional cost. As soon as they're available to you and covered by insurance. Everyone follow what I'm saying? terms and conditions apply. But you can find out all the details that my link on the pod comm forward slash juicebox there's links in the show notes of this podcast player that you're listening in right now. Or links at Juicebox Podcast comm I mean, in case you can't remember on the pod.com forward slash juice box which I feel like you can do. Alright, does everybody get what I'm saying about Omnipod because it's time for one more thought. Gee vo hypo pen has no visible needle, and it's the first premixed auto injector of glucagon for very low blood sugar and adults and kids with diabetes ages two and above. Not only is chivo hypo pen simple to administer, but it's simple to learn more about. All you have to do is go to G evoke glucagon.com forward slash juicebox g vo shouldn't be used in patients with insulin, Noma or pheochromocytoma. Visit GE Vogue glucagon.com slash risk. I have a little more time here. So let me tell you about the diabetes pro tip episodes from the Juicebox Podcast. They are management focused. It's me and my friend Jenny Smith. Jenny is a CD and she's had diabetes for 33 years now. And we talk through the concepts and ideas that are mentioned here in the podcast. So the diabetes pro tip series has them condensed down into topics. They begin at Episode 210 in your podcast player, or you can find them at diabetes pro tip calm or at Juicebox Podcast calm. And if you're really newly diagnosed, you might be hearing a lot of terms that don't make sense. Go to that same link diabetes pro tip calm, and you'll be able to find the defining diabetes series from the Juicebox Podcast. simple terms that may not be simple to you explained quickly, easily and in a fun way. So not only will you know what the term means, when you're done We'll know how to use it. A hammer is not a hammer until you know how to bang on a nail. And if you've never seen a hammer before, well, that can be confusing. So go find out what a rage boluses Basal insulin, it's so many other words that you may be hearing for the first time if you're newly diagnosed and using insulin. Okay, guys, last thing, they're not sponsors of this episode. But if you're hearing stuff you're liking about Dexcom using my link would be a big deal to me. dexcom.com forward slash juicebox. Let's get back to Jake.

Like the Way Photoshop does it, you can click on the beginner the intermediate or the Advanced tab. And when you move up, you get more features is that anything that's ever talked about?

Jake Leach 21:04
It is it's a I think the one of the ways that I see CGM is it's it's an education tool, right? You learn so much it You mean it helps you manage, but it also you learn over time as you use it. And so the way that we construct the apps, the idea is that there's a user journey when they first when you're first starting out and CGM. And then once you have learned how to use the product, you start gaining more insights from it. And so you kind of step it up. And I think, you know, there's so much innovation going on in the space of insulin delivery, whether it's the automated insulin delivery systems you mentioned, or, you know, algorithms around multiple daily injections and pens, and smart pens, we're just starting to see smart pens come out. And so there there is definitely a user experience journey where they you gain more experience in managing diabetes. And the concept of a more advanced app or more advanced features is definitely something that we talked about. And I think over time, you know, our goal is still to have an app that can serve customers in the way they want to be served. And so the ideas with the API's and the rest of the ecosystem, there's tools, our pump partners, you mentioned, tanaman, and insolate. All of those are designed, they're powered by Dexcom CGM, but it's designed to, you know, give users choice. But you know, how do you deliver insulin? All of those things. And so we try to support that as much as we can.

Scott Benner 22:29
Okay, so before I jump in and barrage you with questions that hopefully you can answer, maybe you won't be able to, I just want to say thank you, because you said something a moment ago that I believe to be 1,000,000% true. And everyone listening to this should know, if you've gotten any value out of this podcast as a listener about how to use insulin, most of what I was able to teach myself came from that little screen in front of me with that Dexcom like watching that graph, seeing insulin impact the numbers, seeing food impact and watching the speeds. I learned more in a handful of years than I think I would have learned in a lifetime of not seeing that I don't even know. Like, I don't want to sound like I don't want to be ham fisted. But I don't generally, I generally, genuinely do not know where my daughter's life would be right now, if you guys didn't do this, this seriously, like I heard a one C is consistently in the mid fives, she eats whatever she wants, she's active some days, not active other days. It's, um, it changed her life. I mean, it changed everyone's life. But I don't think I'd be able to do what I do. If it wasn't for what you guys do. So I think

Jake Leach 23:37
it's so it's so great to hear. It's, it's, you know, the best part of doing what we do is when we hear, you know, feedback like that, that people get to live a normal life with diabetes. And it's one of the things that we've seen it over time, you know, with our first systems they were they were helpful, but they weren't a great solution for everybody. And over time, with remote monitoring, and all the you know, automated insulin delivery. And it's just so exciting to see. And you're so right about the real time feedback, whether whether it's type one diabetes, or even type two, we're seeing you know, recently we saw that, you know, folks on Basal insulin only using CGM can really improve their time and range by using CGM, because it's just, it's feedback you never had before.

Scott Benner 24:16
So I'm seeing that too. There are people listening to this show now and joining the there's a private Facebook group for the show that's like up to like 13,000 people, or more and more type twos coming into it. Yeah, they're having similar experiences just by listening to the conversations. So anyway, I genuinely mean that. So I really appreciate it now, Jake, I'm, I'm vexed here because I buried what I think is the thing people want to know the most about 10 questions into this, but I'm just gonna start off with it so people can, can can get one bit of happiness if you're able to answer this when the new app comes out, and I'll ask you if you can tell me when later but when it comes out, is there any chance that delta will be on their rate of change? I can't I can't exactly answer that. Sorry. Okay. Do you know that that is something people really, really want? I do? Yes, I do. Absolutely. Do you go to work every day trying to make the patients happy? I do. I do. Absolutely. And we'll just move on. That's fine. So I guess maybe I should ask. It. Will. Will the new app launch with the new device?

Jake Leach 25:25
Yes. Yeah, absolutely. it'll, it'll come together. It's a it will remove your G's. When you upgrade to G seven, you remove the G six app, and you download the new g seven app. And then you enter in your your credentials for your account, your your Dexcom, username, password, and you're off to the races with G seven.

Scott Benner 25:40
That's it. Okay. I'm going to ask you a couple of questions that I know that the answer's no to. But I think it's good for people here because they have this thought all the time. Can you make your receiver Wi Fi enabled? Like

Jake Leach 25:54
so? It is a great question. And we debate we debate it all the time. And it is technically possible to do it. And so and we know that that is a request, we you have to put the hardware into it to make it compatible with Wi Fi, you have to put the silicon in there, the chips, but the the current one is not my Wi Fi enabled. And we are launching a new receiver with G seven, it's a new display device. But and that one is not Wi Fi enabled. The idea there is we wanted a very, very simple display device for users that prefer the receiver. But it's helpful to know that Wi Fi is a desired option. I assume it's around being able to remote monitor when in a one five range with the receiver is what I'd expect. Yeah,

Scott Benner 26:42
so the answer the questions usually are around the convenience for younger children. They and then this runs right into this next question which I don't have the technical background to explain to people but I feel like you do. Why? Why can't people be connected while they're swimming or in a bathtub? Can you just very simply, I mean, I'm assuming the Bluetooth signal just doesn't travel through water. But

Jake Leach 27:07
that's exactly what it is. It's it's basically that the Bluetooth is a 2.4 gigahertz is the frequency. And what happens with that higher frequency around water is the water absorbs the radio signal. And so it can't transmit. And so 2.4 gigahertz is not as frequently not used for anything that's in either implanted or under, you know in a body water or anything but just because the it's not an efficient frequency for use in anywhere around, you know, inside water or tissue. The reason we use Bluetooth is because of its it's such a ubiquitous standard for mobile phones and with with our our original goal with G five was to get to a mobile experience with our CGM. And so we moved to Bluetooth. And it's been a great tool or pump partners have adopted it. But the one thing one of the things about it is it doesn't work well underwater.

Scott Benner 28:06
Just it's You have no idea how many times somebody was like, why does it not work? When I go swimming or above? I'm like, Well, I think physics, but somebody wants to know if in the future, there'll be an automated way of reporting a failed sensor

Jake Leach 28:21
100%. So one of our a very important goal of ours, it's a company wide goal is to simplify that experience for users when a sensor does fail. And we know that there are some pain points in that process of trying to get a new sensor and a replacement. And so we we very much want to make the experience simpler with automated tools. And it's it's the way that we think about a lot of things that we recently launched a new FAQ page or that you can access from within the JSX app. And this has a lot of answers to basic questions. And you know, more than half of the phone calls we get at the company or around people asking questions on how to use the product. It's not really tech support in terms of, I have an issue that I need you to help me resolve. It's just simple things. And so we've updated the FAQ page, that's a first step in we want to build more automation into the apps to help users solve problems quickly, without having to pick up the phone and call us. They were still there if they want to call, but we do want to help them resolve their issues as fast as possible.

Scott Benner 29:26
Okay, I'm going to make a note about that. I want to bring something up to you afterwards. That I think is interesting, but maybe not interesting for everybody listening. Will it work with tide pool at launch? Will it work with on the pod five and tide? So tide pool loop is one of those things that I guess. I mean, I probably thought we were gonna see it by now. And now I realized that I was kind of crazy for thinking it would come so quickly. But how about that will will g7 work with those devices.

Jake Leach 29:57
So g seven the Bluetooth functionality Seven is very similar to G six, but we've made quite a few enhancements to it so that our partners will have to do some updating to their communication protocols. That's one and then two, they have to get the product approved for use with their system. With g six being an AI CGM g seven is intended to be an AI CGM. When approved by the FDA, that makes the path to upgrade for those for our pump partners and our insulin delivery partners, it makes it easier for them, it's a faster process because the performance of the product proven out. It's important to note it's I CGM. For AI D, there are different categories of ai CGM is the one g six is the only one that's in the category for automated insulin delivery. And so the tools are there for those those partners and we are already working with a number of our partners on G seven integrations that we have been for quite a while. And so they're they're moving quickly. And so those approvals, timing will be based on those companies, how quickly they can get their validation through the FDA, but we anticipate that it will be as fast as they can do, do you have employees that are bridges to pump partners? We do we actually have an entire group that reports into me, that's, we call it our alliance management group. And what they do is they work with all of our different partners, digital health partners, insulin delivery partners, and they're really the focal point of communicating with the partners. And then we have separate support teams like our we have a separate Bluetooth support team, specifically for helping people integrate with our transmitter, particular pump partners. And then also testing those implementations to make sure they work properly.

Scott Benner 31:42
So this partners aren't left to their own devices, they're not over there scrambling around being like I don't know what happened, dig, they can contact, you have meetings together all kinds of stuff like that.

Jake Leach 31:51
Yeah, we strive to be the best partner possible and have all the support we can. Because we know that by supporting partners like tanaman, sled and others, it's all about, you know, serving the customers and giving them choice. And so the more that we built around g six, and G seven, the better.

Scott Benner 32:09
So in for simplicity, g seven comes out it hits when it hits, the partners need to get it, get it set up, do the testing, get it to the FDA and get the okay and the reasonable to consider they're working on that as

Jake Leach 32:22
we speak. Yeah, yeah, exactly. g7 needs to be approved first. And then they will get their approvals very, very quickly. I expect we already working on those integrations and doing testing, which IE seven and multiple partners.

Scott Benner 32:35
Okay, so I put my foot in my mouth when I was talking to Kevin, so I will know not to approach it the same way this time. I will I will change this question to can you please explain to people why it is difficult to go directly from the transmitter to an apple watch?

Jake Leach 32:50
Hmm. Scott, that is a great question. Okay, so really exciting. So there's a, I'll start in the beginning. So when Apple first announced, hey, we were opening up Bluetooth connectivity directly to the watch the core, core Bluetooth. And we were one of the companies that they said they're giving access to. And we got really excited, we started working with them on it. And what we started to recognize is that when you communicate between the transmitter and the watch directly, the watch becomes your primary. Well, in our language, it's your primary display. It's the it's not only giving you the real time CGM readings and access to the data. It's also your alerts and your alarms. And so one of the things that we pay a lot of attention to and work really hard is to ensure that users always get their alerts and alarms, even when their phone is like for example, in the phone, it's potentially configured in a Do Not Disturb mode. And they don't realize that that's how they've done it and they're not going to get their CGM alerts. And so within like, for example, the Android app, we actually detect whether that setting has been applied to GE six, and we remind you to turn it off, do not disturb you want your alerts. So the alerts are so important. And one of the things that as we've worked with Apple on the integration, we started to realize that there were a lot of use cases on the watch where users would not reliably get alerts, things like when the watch would go into a lock state, like when you took it off. Originally, it wouldn't, you wouldn't, your alerts would suddenly stop working. Okay, and so really not a safe place. So what we've done, though, over time is and there's been multiple watch OS releases over time. all we've done is basically focused on making sure that those alerts alarms come through, I'm happy to say that we have figured out how to do it. And we figured out we have the Bluetooth functionality that we actually implemented that quite a long time ago. The Bluetooth functionality to the watch what's needed to be in the transmitter inside the g7 to talk directly to a watch. It's in there. And so the next final step is to release a g7. When we release g7. We will need to release a g7 app that has the watch direct to watch functionality in it. And so we're kind of finalizing that the exact timing. I'm still, you know, landing exactly when it's going to come out. But it's going to be soon. And really excited about the functionality. It's been a long time coming. It's been even internally a bit frustrating going back and forth over those use cases and making sure we have every single one of those potential cases where the alerts wouldn't work. Make sure it's covered. And so we're in a good place. Now we're really excited.

Scott Benner 35:26
I laughed, because if anybody pays attention to Ilan Musk is it's coming in two weeks, it's coming in two weeks. I think that's your version of it. We got the Apple Watch thing. It's coming. Because Yeah, I feel like I've asked three different haircuts of you that question, you know, 100%, and it's just so is it going to be just the latest version of the watch? Or will it be any backward compatibility at all? Yeah, no,

Jake Leach 35:49
there definitely is. I think we go all the way back, I think two series, the series one watch even will work. Okay, I believe, yeah. So it actually it goes back quite a ways apples, we support it, we tried to support at least, you know, two OS versions back, and then also older phone hardware. And so the watch hardware, it'll go back quite a bit.

Scott Benner 36:11
I have to say, for me, I loved Apple Watch, right until my eyes wide until I turned, I got my late 40s. And I'm just like, why is it so small, all of a sudden, became less valuable to me. That's great news. You think? I know. It's hard to say. But I guess here's the place where I'll ask. So I'm gonna ask the next question. Do you have any timelines for g7? Right now?

Jake Leach 36:34
Oh, we've got we've got timelines completely locked down. I just can't share them. Okay. But we're very we our launch planning is well underway. Everything is, you know, we've got our submission that we're working on. So we're really excited. And yeah, we've got to lock that in, I just can't share with the timelines are,

Scott Benner 36:53
let me ask a different question. When you were getting ready to launch g six, how much sooner before the launch? Did you start working on that stuff?

Jake Leach 37:02
We so with G six, we did start working on it quite a ways ahead of the approval. But with G six, the approval came a little faster than we actually had planned. And so we had to react to that. And we've you know, we didn't at first have all of the capacity, we couldn't build as many as we wanted. So with G seven, we've taken all of those learnings from G six, and built it in up front so that we have a launch ready date well ahead of when we expect approval. And so we in the capacity that we've built up in manufacturing, we already have lines up and running. But we've we're continuing to build more lines. And we want the transition from G six to G seven, to be as fast as possible. We want customers using the latest technology, you want to get into their

Scott Benner 37:49
hands when we pay you a compliment for my wife. So my wife is drug safety guru, both devices and like she's like the central brain for some pretty big places. And she said that you guys did a really good job of understanding the regulatory process. And and she's she said she's kind of amazed. She's like, newer companies don't usually figure out how important that is right away, but that you guys really did. So I don't know who's who thought that was important all those years ago, but that one little decision makes things go faster.

Jake Leach 38:20
For he does here it does. And you know, we approach our relationship with regulators as a partnership. They're just as interested in getting the latest technology to people as we are. They just want to make sure that products are safe, and they do what they say they're going to do. And so you know you as a partner, you work together to find better solutions on How to Get Products approved as fast as possible. I think the I CGM designation for G six is an example of that, you know, working with the FDA and on how to you know, what's the real performance bar fridge for a CGM is actually, which is six. That was the first time there was ever a performance bar. That was stated for CGM, until g six, it was all about, here's how the product performs. And this basically labeling it to that now it's there's actually a performance bar that's quite high to that you have to meet to be in that designation. So yeah, we definitely value our relationships with regulators. And we spend a lot of time investing in our regulatory team, making sure that we've got the best and brightest there. So you

Scott Benner 39:20
seem really comfortable and and kind of proud of the next product that's coming out. So what are the real world like? Are we going to see increases in? I don't know stability? Are we going to see increases in in what it's doing? Like, is it going to be better at what it's doing? How do you think of it?

Jake Leach 39:37
it's it's a it's an improved product. One of the things I think about when she's seven is that because of the number and the size of the clinical studies that we've run ahead of actually running the study for approval. We ran a lot of studies and all what that was is to understand the product performance and then tune our glucose algorithm to produce the most accurate, reliable readings. And so it is an enhancement over g six. One of the things that we're from a technology perspective that we're most excited about is the 30 minute warm up on G seven. So that's was quite a technical feat, you know, for I've been working on CGM for more than 20 years. And the startup has always been one of those things that it takes a certain amount of time for the sensor to acclimate to the body, as well as to hydrate. There's an electric chemical component. So there's all these things to it that it we've kind of been stuck at Dexcom at that two hour mark for for many, many years. And now with the g7 in the 30 minute warm up that we've produced, it's it's really exciting when you when you put on a g7. And by the time you pair it here, you've got about 25 minutes before you see glucose readings, which is just, it's better for all kinds of reasons. The automated insulin delivery system starts getting CGM readings right away. You don't have to wait the two hours. And so we're from a technology perspective, that's one of the things we're really excited about.

Scott Benner 41:01
How are you seeing accuracy in those first number of hours?

Jake Leach 41:05
It's good. Yeah, it's really good. You still it's, you know, we with CGM in general performance in the first days is more variable than the other days. But it's it's still very good. And it's just gets better on the second day and throughout. So it's, yeah, g7 is is a great product. One of the other things that is really exciting about it is when you deploy it, the the sensor starts the session starts. So there's no more this concept of I want to start my sensor session, then the new concept, which you seven is I want to connect to my g7. And it's already up and it's already up and running from the second you press the

Scott Benner 41:41
button, well, from a person who has once thought that they touched the Start button and didn't, I appreciate that very much. So I'm going to start jumping around in my head here, I can feel it. But there's going to be it's all one package right like the package comes the entire thing. So for people are thinking about g six, and right now you have a sensor, the sensor goes on with the adhesive, there's a plate there that you clip the transmitter into. But now this whole thing is just one piece, right?

Jake Leach 42:10
It is it's just one piece, it all comes in a box and even the box. purposefully, we wanted to minimize the waste. And so the boxes like I think it's 67% smaller in volume than g six. And it's just a little box that has the sensor in the transmitter applicators, all one piece. And it's a smaller applicator than g six. But still large enough, you can hold it nicely. And it's a single button press and deploys a sensor. But yeah, it does simplify things that simplifies things access perspective, right, you don't need a separate prescription for a transmitter, you don't have this concept of I need to, you know, 90 days after Remember to get a new transmitter, it's just all in one. And you know, one of the other exciting things that I look to with g7 is that, because it's a new transmitter with every device, it allows us as we want to make upgrades to the product, we can, you know, there's not this concept that people have to wait till their transmitter expires to get the latest technology it's coming out with every time and so we you know, we recently made an update to our transmitter to reduce the time where we would see sensor error. So that's the time where the sensor has failed. But it's not showing glucose readings. really significant improvement for for customers who had had that issue, we put in the transmitter, but you can until you know people get new transmitters, they didn't get the functionality. So that's one of the things I really like about the concept of it's an all in one, all the technology is in the one piece.

Scott Benner 43:40
So if it gets confused, and it it won't show you a number because it's not certain of it, you're seeing them come back more quickly after that.

Jake Leach 43:48
Yeah, that we with, particularly that sensor error rate with these new transmitters, if we're for G six, it's 50% less time spent in that sensor Earth and we had with the previous version g sex and what that was, was just getting more experienced with the product over millions of sensors, you start to better understand when you when you know it's working and when you don't, because we want to make sure that we're only displaying reliable data. And so when you see that sensor error, it's the system is there's some sort of signal in the sensor that is telling us that we can't rely on that reading. And so that's why we we show the sensor here and often it comes back, there's a lot of more transient. And so that's kind of what we've done with that new version of transmitter dial it in.

Scott Benner 44:32
So you're, you're starting to have this historical knowledge of of your product and you're starting to be able to make it better and better. Do you think that in 10 years, we're laughing at the size of this thing and and then there's a warm up or do you think there's a ceiling to this? No,

Jake Leach 44:51
I don't think there's a ceiling there's there's so much innovation still to go in the space and our pipeline is very full of You know, even reliability enhancements, sensor accuracy? I mean, I often get the question Is it good enough. And while it's really good, and, you know, tremendous number of people use the product and get great, great success with it, I still want it to be better, I want it to be more reliable. I want it to meet every user's expectations. And so there's plenty of work for us to continue doing. And so I think, in 10 years, we're going to be a whole nother space where Yeah, we'll be laughing at the size of today's devices, we'll be laughing, that is the warmup period, what's that, you know, it's just that we're gonna continue to push down below. And in, it's exciting, the way we do our research is, we have a lot of different programs running independently. And as they prove technical feasibility, we start to bring them together. And so all of our products over time, and JSX is one of the first that was a very large group of new programs that all came together, and we built g six with that. We know years ahead of time, which programs we're going to put into it. But like for g8. Right now, I can't tell you exactly all the technology, it's going to go into g8. Because a bunch of it's still under feasibility. But soon, we'll start that that protocol start taking shape and in our r&d team. And so we've we've got plenty to come.

Scott Benner 46:14
That's really cool. The new form factor of G seven, do you think it'll cut down on compression lows?

Jake Leach 46:20
I think yeah, it you know, it's debatable whether it will actually cut down on it, we see more compression in the arm actually, just in general, it would use x and, and in G seven, there's just wearing a dice in the abdomen seems to be less prone to compression. But it's it's really a personal thing for users, they, you kind of have to figure out what works for you. compression is a reality of physiology, when when the tissue is compressed, there's less perfusion, and you don't get, you know, the same glucose flow there. And so it's one of those things that we have some creative concepts of how to in the future, how to continue to reduce it. But it's still it's still there, it still can happen. What do you think it's a software fix? Well, it's a really good question, Scott, I think with software, you can detect it. But you can't you can't even glucose sensor can only measure the glucose it can measure. So it's more about predicting or anticipating it, detecting it, and then how do you react to it and respond? I think that's part of it. The other part of it is mechanical design. We're always learning. It's so funny over being in this industry for so long, and working on so many different generations of sensors. We still learn every day more and more about the technology and how to make it better.

Scott Benner 47:36
Well, you You're the one that that explained the compression low to me in a way that I could understand it. And I wonder how many people realize that, you know, if you roll over on it, you're dispersing the interstitial fluid, you suddenly get a lower reading the readings actually accurate for the spot around the wire, right, but not accurate for the amount of glucose in your body. It's like putting oil in a bowl of water and then putting something in the middle that repels the oil, the same amount of oil still there. You just can't measure it in the center anymore. It's a great analogy. Yeah. So I just I knowing that is really helpful. And then once you can see it, it's fascinating, right? Like it it, it jumps your heart, like if your kids blood sugar's 80. And then all of a sudden, it's 55. You're like, oh, but after a while, like, I don't know how to explain it. But I know I've told you this before the three hour line on the graph is the most valuable for me, I can infer the most out of three hours. And so there's something about the band in the drop, where I'm like, Oh, that's a compression low. And then I can relax. And then it's interesting. It's sort of the way you guys learn to and I go into my daughter's room, I say roll over, you know, she rolls over, I don't I get to go back to sleep, because I'm not worried about it ever. You see that a few times. It just makes sense to you all the sudden your heart doesn't jump anymore. And you have this historical data that you can start making better decisions with and I don't think people would think of it that way. But even what's going wrong, quote unquote, is a learning experience. I it makes me want to ask you about body chemistry. So you make a product, it does the thing, but every person you put it into is different. Do you ever run into people who that CGM just flat out will not work for.

Jake Leach 49:18
So in the past, in our first series of products, the STS three day in the seven, we actually saw that we some people about and actually it was quite a high percentage. It was like 25% of the people that tried our product. We couldn't get reliable glucose readings from them because it was the way that their body was interacting with the sensor. And the as you mentioned before, the glucose sensor will accurately measure glucose but it's the measure of the glucose in the vicinity of the probe. And one of the things that happens with sensor probes when they go into the skin is the body can react to them. And it sends you know, macrophages, a bunch of things occur in the space of what we call the sensor wound. It's actually a little little pocket. And so over time, what we've done is both with the working on the probe, kind of characteristics of the actual sensor probe, and the materials that we put on the sensor probe that do the glucose sensing. The other thing that's really important about those materials, glucose sensing is that they're biocompatible with the body, and not just one person, but all customers. So today, we don't see that with g7, we see people, we do see people, they'll have a higher rate of sensor error, because and a lot of that has to do with physiology and differences. But we didn't, we don't see folks that the product won't work for like we did in the past. And the way that we got rid of that issue was sensor probe design and the materials on the on the sensor, those are that's how we solved the problem of certain folks couldn't use it, it was it was challenging to tell them, you know, this product just doesn't work for you. But we're working on a new version, and then we're able to overtime. Pretty good with Gen four, which kind of resolve that issue.

Scott Benner 51:01
I'm interested to know. piggybacking on that, did you see any similarities in those people? Like physiologically, did they have low magnesium or like you don't I mean, like something that you could point to and go, there wasn't,

Jake Leach 51:12
we didn't find anything, but we could just from the sensor signals, we could see that their bodies were reacting similarly to the sensors. And so we could tell that the sensor signal wasn't accurate, because of some of the signatures there. And the signatures were similar. But what it was in the physiology, exactly. We, we don't know, it's one of those things. That's the that's the one of things we learn a lot, as we do more and more clinical studies. And, you know, we're still, like I said, learning every day, you you, there's still more to learn about the physiologic reaction to sensors, and the wear time, and the longevity of the sensor and quite a bit there that we're doing some exciting research on.

Scott Benner 51:50
Yeah, I would be so interested to see the blood panels of every one of the people who says the same thing. You know, I know, that's probably not even something you could do. But I think there's, I think there's a lot for people's health, that we're beginning to understand more and more, that if you have that data, you might really start being able to help people in ways you never imagined. So, you know, just the littlest things. Sometimes it's just the nutrient or you know, something you need, or it's just interesting. Hydration even is so huge, right? Like how often you tell people that your sensor is acting wonky Drink, drink a glass of water, you your interstitial fluids not moving around. So it definitely helps. How much time do we have? Jake, do you know what we did for this?

Jake Leach 52:30
ad? We've got another? I think we have about 10 more minutes. All right, here

Scott Benner 52:34
we go fast pace. Any more flexibility for alarms? Different snoozes? Can are people going to be able to set up a night time versus a day time and that school versus an at home?

Jake Leach 52:50
What I can say is yes to those those things, we definitely have been listening to user feedback and came up with some really creative solutions to safely provide those types of features like different snooze and some things. I can't go into all the details. Okay. But we definitely listen to customers. And that is the features are built into g7. Excellent.

Scott Benner 53:13
Android, people want to know, if there might be more frequent updates to Android phones, I don't have an Android. So I don't know why they're asking.

Jake Leach 53:20
Yeah, it's, it is so androids just it's a more complex process. Because, you know, with Apple, the it's both the manufacturer, the hardware, and they've manufactured the operating system. With Android, you've got different hardware, from different manufacturers. And then you have the OS coming from Android. And then each manufacturer does their own version of the iOS. And so we have to do quite a bit of testing. One of the things that we are focusing on investing more in is our bandwidth and capability to do testing of mobile phones and apps. And we've been overtime. Sorry. So we've been focusing on expanding the capability. The other thing too is, over time, we've gotten quite good at testing and learning where things can have issues basically the point of compatibility, what we have to do is we have to prove that the product will reliably work with the mobile device, the Android phone, for example. And we want to it's really generally around the Bluetooth functionality is the primary place where we have our main focus, making sure that Bluetooth works reliably because all the phones have different chipsets in them with different levels of reliability. And so we have to verify that users are going to get a good experience. And so when we say a phone's not compatible, it's not necessarily that it's not compatible. It's just we haven't tested it and proved it's compatible. So we do you customers will see an acceleration in our compatibility of devices. And the chance to do app allows for note taking,

Scott Benner 54:51
like this is what happened right here. They see something and they want to leave a note.

Jake Leach 54:55
There there is there are some specifics around two things. One We made event entry even simpler so that you can get into there and enter some things. And it specifically for entering text, right at that one actually, I'm not positive that I know that's in the in the feature list. But I don't know if it's in the initial,

Scott Benner 55:18
I'll tell you why the person asked, so maybe it'll feel important to you later, she said that sometimes like a compressional is an example. Then they do a finger stick, but then the endo doesn't believe them. So. So they're, they're having to fight with their endocrinologist? No, he's not really low there. Because then the endo wants to change their Basal insulin that it turns into this whole like, like landslide of problems. Got it? Okay, they want to be I hadn't heard that one before. So three months later, when you're like, I don't know what happened on June 10, at three o'clock, but it would be nice to be able to notice is what the person saying I'll go verify, hey, it seemed seemed interesting to bring up a lot of questions about alarms, and being able to schedule different alarms. The ability to dismiss a notification with a swipe people are asking about, so yes, well, that yeah.

Jake Leach 56:07
So. So the swipe on the phone or on the

Scott Benner 56:11
like on your screen?

Jake Leach 56:13
Yeah. So when the notifications come up, you have to go in and acknowledge it. And so you still do have to acknowledge the the alert. And so that's it. That's an important kind of guarantee that we know that it was acknowledged. So you do have to go in and acknowledge it through the window.

Scott Benner 56:32
I have a question that's not on here for myself. Any chance we'll be able to see the blood sugar on the lock screen? Possibly possibly. How about the follow up? Is that getting an update to?

Jake Leach 56:45
Yeah, so that's a great question, Scott. So one of the things that I've always wanted to do is I want more updates to our follow up, what we had our teams focused on was internationalizing, g six. So we are continuing, you know, even just recently introducing g six to more countries. And so the team was really focused on that, and also this new g7 app. And so we weren't doing as many updates to follow as we wanted. So one of the things about our expanded software capacity is our our ability to make updates to follow. And so we have a great list of features that we're working on implementing into follow. The great thing about followed is it is independent of G six or G seven. It works with both. And so we'll continue to update follow. And then when g seven comes out, it'll seamlessly work with it.

Scott Benner 57:32
Right? So like that. I think the biggest thing people want to know is whatever is happening on the G on the AP side, can I see that this is a no data or there's a sensor error, or that kind of stuff will warm up that top

Jake Leach 57:45
top on the list of things, your number one priority for fall. Okay,

Scott Benner 57:49
why there's so many people are really like ninjas about how they use this app. Will there be changes to the app right now the soonest we can get a low notification is after 15 minutes are two and a half year old can drop super fast. Is that true? That it's 15 minutes?

Jake Leach 58:04
I'm trying to follow that question. Specifically,

Scott Benner 58:07
if I set a low level of 70, as soon as it hits 70, I just turned the slider right now to zero, right? And then I get it right away.

Jake Leach 58:15
Yeah, it alert alarms. The other thing too is the urgent low soon, is also can be can be helpful for you know, rapidly dropping pretty good that scenario, right? If they're rapidly dropping, you know, urgent, listen can be really helpful to that that kind of predictive alert. But know, though the alert happens. goes off when you cross the threshold.

Scott Benner 58:37
Yeah, I think that, um, I can say for myself, I found that confusing the first time too, because it kind of goes in 15 minute increments than the last one zero. And I think it feels like but you just set it to zero. So that's your point earlier, but I guess you, you know, do something you think it's right. And then people are like, Oh, be better like this. And, you know, sometimes it is I'm skipping all over the Delta rate of change questions. Yeah, people want to know about like snoozing overnight, like things like that, I do think you did a great job of explaining why that's important. Like, you can't tell somebody you're set, you're selling them a thing that's gonna beep if their blood sugar gets low, and then they're suddenly allowed to decide, well, it doesn't because you've made a medical promise to them now and the FDA is let you sell this item because of that, that is what is happening, right?

Jake Leach 59:26
That's right. And and it's in the worst case scenario is you you did something like silence the alert on accident, you didn't you don't know. You know, you're basically putting your phone on Do Not Disturb mode, but not recognizing that it's going to actually silence your glucose alerts that are so important. So that's, that's what it's all about. But with g7 we have come up with some great ways to be able to do that safely and inform users and allow them to do things like snooze alerts I, I get a lot of feedback, and even my own experience with the product where we really want to know if there is a low alert Going off, and you really want to silence it. And you're like, Yes,

Scott Benner 1:00:02
I know I'm low. And I don't want to be reminded for a while, that functionality is not in G six. Now, we have built that type of functionality in the g7. Cool. I'm going to this last question is not really a question, but I thought you would find this amusing. So it's five seconds, after you've announced that there'll be a 30 minute, you know, delay to use it, and somebody wants to know, if they can soak in the new sensor.

Jake Leach 1:00:26
You know it with g7, you can apply a sensor and it's going to start, it's going to start its warmup period, the second you deploy it, so and then you just, you know, you can, you could start it if you wanted to. And one of the fun things about it is sometimes if you if you deploy g seven, and then, you know, get busy and forget to pair to it, and then you actually pair to it. And you know, you started it an hour ago, you're gonna get 30 minutes a day to suddenly on your phone.

Scott Benner 1:00:51
So So if I'm wearing a G seven, I have an hour and a half laughter, three hours left, I could put on another one, and stay paired to both of them, or they want to do additional one

Jake Leach 1:01:02
as a part of the initial one. And then when you're done, you go on and move over to the new one, through Bluetooth settings, I would just go in and do it within the app, you just say I'm starting a new sensor.

Scott Benner 1:01:13
And you just paired. Jake, your diabetes, geek bone a few days just went up crazy with. It's amazing. I'm super excited. I'm gonna let you wrap up here in a second, I have to say that in the middle of this conversation, it went by so quickly, you were a font of knowledge about this, like you, obviously, you've been working their way through. But you said something in the middle of just about not having a transmitter anymore. That made me realize that all of that anxiety that comes from insurance, and is there going to be one at the end? And what happens if I miss it that really does almost disappear now because of the form factor, right? Yeah,

Jake Leach 1:01:52
it's a lot simpler. You don't have a separate transmitter prescription that you have to fill or access to depending how you get your product. Yeah, it's all it's just you all you need is a sensor when you're traveling, you don't have to like worry about when the transfer is going to expire. You basically just need to love g7 sensors. And yeah, you'll always have a fresh transmitter with you.

Scott Benner 1:02:11
Does this make it more reasonable that they might be accessible in pharmacies more easily now?

Jake Leach 1:02:16
Yeah, we're seeing it does help with that. But even with G six, we're seeing more and more access in the pharmacy. We see that that's, you know, with the insurance, the individual has will cover it through the pharmacy. That's our preferred route, because it's simpler for the user. It's actually simpler for us. So that we will see greater and greater CGM access in the pharmacy. Okay,

Scott Benner 1:02:41
well, Jake, thank you. I literally could have done this all day with you. I love when you come on. It's a blast. I appreciate you giving me the time. A huge thank you to one of today's sponsors, g Vogue glucagon, find out more about chivo hypo pan at GE Vogue glucagon.com Ford slash juice box, you spell that GVOKEGL you see ag o n.com. forward slash juice box. If today's episode got you thinking about a Dexcom, head over to dexcom.com forward slash juice box. And I want to also thank Omnipod for sponsoring this episode. And for making the Omni pod promise.

One more time because this is new and exciting. And I want to make sure you know you of course can get a free 30 day Omni pod dash trial at Omni pod comm forward slash juice box head over to see if you're eligible. But there's also no need to wait for the next big thing. The Omni pod promise says to you that you can upgrade to Omni pods latest technology for no additional cost as soon as they're available to you and covered by your insurance terms and conditions apply. And you can find all the details at my link. But really, this time in this moment, soak up what that means on the pod makes a thing. If you want it, you can go get it right now. If they should ever make something else, as long as it's covered by your insurance, there's no other impediments. So it's not like oh, I just bought the dash. I can't have the new thing. That problem does not exist with the Omni pod promise. All the details are on the pod.com forward slash juicebox. Last thing, these episodes that are around technology often bring in a lot of new listeners. If you're still listening and you enjoyed this, please find the show in a podcast app. podcast apps are free you can get them anywhere for Android or iPhone. If you can't find one, go to my website Juicebox Podcast calm there's links to them there. Subscribe to the show and give it a chance. Just Just check it out. I talked earlier about the diabetes pro tip episodes and the defining diabetes episodes. So if you're still listening, and you haven't checked those out yet, or you don't know the show, I'm just gonna read you a quick review. This person left this review in 2000 on Apple podcast, this podcast has changed my life. I had a desire to lower my agency and manage my blood sugar's better, but was going about it blindly finding this podcast put everything into a tangible and practical management approach that has taken my agency from 8.3 to 6.3, in less than six months. And that's just right now, it's going to keep coming down. Thank you, Scott. I'll be quoting you forever. I could read you these reviews all day, but it would feel self serving, and I don't want them to feel that way. Just head to diabetes pro tip calm and see for yourself. Try the defining diabetes episodes. Try the diabetes pro tip episodes. Subscribe in a podcast app. Find the private Facebook group for the podcast. 13,000 plus people in their Juicebox Podcast type one diabetes, talking about management in ways that you'll find accessible and easy. Just like you'll find the podcast. I promise you. Fun, light. I know fun and diabetes don't go together. But it's a light conversation that leaves you with a better understanding. Please check it out. And if you don't come back, thank you so much for listening to this episode of the Juicebox Podcast. And for the rest of you. Don't forget to share the show with someone who you think can benefit from it or will enjoy it. Thanks so much guys. Your support means everything. The podcast is going crazy strong right now is because of you just because you listen it's because you subscribe and download and share and I can't thank you enough. I'll be back soon with another episode.